Skip to content
GenoLensGenoLens

RPIA

Chr 2p11.2

ribose 5-phosphate isomerase A

MANE:
ENST00000283646.5

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • White matter disorders and cerebral calcification - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

Disease associations (Open Targets)

  • ribose-5-P isomerase deficiency

    0.75
  • Disorder of carbohydrate metabolism

    0.46
  • hereditary disease

    0.41
  • non-melanoma skin carcinoma

    0.23
  • Hashimoto thyroiditis

    0.21
  • autoimmune disease

    0.20
  • skin neoplasm

    0.20
  • neurodegenerative disease

    0.19
  • hypothyroidism

    0.19
  • immune system disorder

    0.18

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Ribose-5-phosphate isomerase

Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate and participates in the first step of the non-oxidative branch of the pentose phosphate pathway

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.